Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Kinex Pharma of the US Receives Investment from Hong Kong Investor

publication date: Aug 1, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Kinex Pharmaceuticals, a New York-state startup, received a “substantial” investment from Dr. Manson Fok, who is the Founder of the Pedder Clinic, one of the largest private medical practices in Hong Kong. Dr. Fok will serve as an advisor to Kinex on its China strategy. Kinex has developed a proprietary platform to discover new molecules for cancer and immune-modulatory diseases. So far, Kinex has licensed China rights for two prospective cancer drugs to China companies. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors